Genitourinary Cancer Research Review, Issue 1

In this issue:

POUT supports adjuvant chemotherapy as standard-of-care in upper tract UC
Pseudoprogression may occur in docetaxel-naïve enzalutamide-treated mCRPC
Tivozanib superior to sorafenib in the third or fourth-line settings in metastatic RCC
RANGEs show benefit to ramucirumab plus docetaxel for advanced platinumrefractory urothelial carcinoma
Surgery in the primary tumour site for metastatic urothelial cancer
Hospital volume determines survival after radical cystectomy
Impact of performance status on treatment outcomes in patients with UC
Olaparib for metastatic castrationresistant prostate cancer with DNA repair gene aberrations
Cardiovascular risk factors and disease after male germ cell cancer
Enfortumab vedotin in patients with Nectin-4–positive solid tumours

Please login below to download this issue (PDF)

Subscribe